MedTrace Logo

Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers

NCT04334876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 571

Last updated 2023-04-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to validate the use of a rapid, at home, point-of-care (POC) SARS-CoV-2 IgG antibody test in high risk healthcare workers. Additionally, we would like to evaluate the incidence of seroconversion in this high-risk population and to identify possible candidates for convalescent plasma donation for therapy/prophylaxis.

Conditions

Interventions

DIAGNOSTIC_TEST

SARS-CoV-2 IgG Antibody Testing Kit

A, finger prick, at home test for SARS-CoV-2 IgG Antibodies.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Courtney Rowan, MD · Indiana University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-11-01
Completion
2021-01-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04334876 on ClinicalTrials.gov